{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:01:20Z","timestamp":1774105280926,"version":"3.50.1"},"reference-count":124,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Thirteenth \u201cFive Years\u201d Project in Science and Technology of China","award":["2017ZX10202201"],"award-info":[{"award-number":["2017ZX10202201"]}]},{"name":"National Thirteenth \u201cFive Years\u201d Project in Science and Technology of China","award":["2018ZX10302-206"],"award-info":[{"award-number":["2018ZX10302-206"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Super enhancers (SEs) refer to the ultralong regions of a gene accompanied by multiple transcription factors and cofactors and strongly drive the expression of cell-type-related genes. Recent studies have demonstrated that SEs play crucial roles in regulating gene expression related to cell cycle progression and transcription. Aberrant activation of SEs is closely related to the occurrence and development of liver disease. Liver disease, especially liver failure and hepatocellular carcinoma (HCC), constitutes a major class of diseases that seriously endanger human health. Currently, therapeutic strategies targeting SEs can dramatically prevent disease progression and improve the prognosis of animal models. The associated new approaches to the treatment of related liver disease are relatively new and need systematic elaboration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>In this review, we elaborate on the features of SEs and discuss their function in liver disease. Additionally, we review their application prospects in clinical practice in the future. The article would be of interest to hepatologists, molecular biologists, clinicians, and all those concerned with targeted therapy and prognosis of liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>We searched three bibliographic databases (Web of Science Core Collection, Embase, PubMed) from 01\/1981 to 06\/2022 for peer-reviewed scientific publications focused on (1) gene treatment of liver disease; (2) current status of SE research; and (3) targeting SEs for liver disease. We included English language original studies only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of published studies considering the role of enhancers in liver disease is considerable. Since SEs were just defined in 2013, the corresponding data on SEs are scarce: approximately 50 papers found in bibliographic databases on the correlation between enhancers (or SEs) and liver disease. Remarkably, half of these papers were published in the past three years, indicating the growing interest of the scientific community in this issue. Studies have shown that treatments targeting components of SEs can improve outcomes in liver disease in animal and clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The treatment of liver disease is facing a bottleneck, and new treatments are needed. Therapeutic regimens targeting SEs have an important role in the treatment of liver disease. However, given the off-target effect of gene therapy and the lack of clinical trials, the available experimental data are still fragmented and controversial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.14780","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T03:28:18Z","timestamp":1674790098000},"page":"e14780","source":"Crossref","is-referenced-by-count":5,"title":["Targeting super enhancers for liver disease: a review"],"prefix":"10.7717","volume":"11","author":[{"given":"Zhongyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"issue":"3","key":"10.7717\/peerj.14780\/ref-1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3951","article-title":"The Mediator complex: a central integrator of transcription","volume":"16","author":"Allen","year":"2015","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.7717\/peerj.14780\/ref-2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2017.03.014","article-title":"Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants","volume":"81","author":"Aune","year":"2017","journal-title":"The Journal of Autoimmunity"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/hep.24155","article-title":"Transcription coactivator mediator subunit MED1 Is required for the development of fatty liver in the mouse","volume":"53","author":"Bai","year":"2011","journal-title":"Hepatology"},{"issue":"2 Pt 1","key":"10.7717\/peerj.14780\/ref-4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0092-8674(81)90413-x","article-title":"Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences","volume":"27","author":"Banerji","year":"1981","journal-title":"Cell"},{"issue":"7","key":"10.7717\/peerj.14780\/ref-5","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.4049\/jimmunol.1202838","article-title":"BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses","volume":"190","author":"Belkina","year":"2013","journal-title":"The Journal of Immunology"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1124\/mol.114.096313","article-title":"Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease","volume":"87","author":"Benet","year":"2015","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10637-019-00792-6","article-title":"Identification of a 3, 3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2","volume":"38","author":"Bi","year":"2019","journal-title":"Investigational New Drugs"},{"issue":"34","key":"10.7717\/peerj.14780\/ref-8","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1073\/pnas.0705053104","article-title":"Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription","volume":"104","author":"Bisgrove","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.celrep.2016.09.002","article-title":"Super-enhancers at the nanog locus differentially regulate neighboring pluripotency-associated genes","volume":"17","author":"Blinka","year":"2016","journal-title":"Cell Reports"},{"issue":"9","key":"10.7717\/peerj.14780\/ref-10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1073\/pnas.1711155115","article-title":"BET bromodomain proteins regulate enhancer function during adipogenesis","volume":"115","author":"Brown","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","article-title":"NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis","volume":"56","author":"Brown","year":"2014","journal-title":"Molecular Cell"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3892\/ol.2019.9980","article-title":"MicroRNA-1291 mediates cell proliferation and tumorigenesis by downregulating MED1 in prostate cancer","volume":"17","author":"Cai","year":"2019","journal-title":"Oncology Letters"},{"issue":"10","key":"10.7717\/peerj.14780\/ref-13","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1111\/jcmm.13787","article-title":"CXCL6-EGFR-induced Kupffer cells secrete TGF-beta1 promoting hepatic stellate cell activation via the SMAD2\/BRD4\/C-MYC\/EZH2 pathway in liver fibrosis","volume":"22","author":"Cai","year":"2018","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Molecular Psychiatry"},{"issue":"19","key":"10.7717\/peerj.14780\/ref-15","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.1128\/MCB.20.19.7292-7299.2000","article-title":"C\/EBPbeta, when expressed from the C\/ebpalpha gene locus, can functionally replace C\/EBPalpha in liver but not in adipose tissue","volume":"20","author":"Chen","year":"2000","journal-title":"Molecular and Cellular Biology"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-16","doi-asserted-by":"publisher","first-page":"e0131743","DOI":"10.1371\/journal.pone.0131743","article-title":"Doxorubicin activates hepatitis B virus replication by elevation of p21 (Waf1\/Cip1) and C\/EBPalpha expression","volume":"10","author":"Chen","year":"2015","journal-title":"PLOS ONE"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2009.06.011","article-title":"Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo","volume":"287","author":"Cho","year":"2010","journal-title":"Cancer Letters"},{"issue":"supp 8","key":"10.7717\/peerj.14780\/ref-18","doi-asserted-by":"publisher","first-page":"S778","DOI":"10.1093\/infdis\/jix178","article-title":"Characteristics, prevention, and management of hepatitis B virus (HBV) reactivation in HBV-infected patients who require immunosuppressive therapy","volume":"216","author":"Choi","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"10.7717\/peerj.14780\/ref-19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11926-013-0369-4","article-title":"Genetics and epigenetics of systemic lupus erythematosus","volume":"15","author":"Costa-Reis","year":"2013","journal-title":"Current Rheumatology Reports"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-20","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1158\/0008-5472.CAN-06-4433","article-title":"Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT\/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade","volume":"67","author":"Datta","year":"2007","journal-title":"Cancer Research"},{"issue":"51","key":"10.7717\/peerj.14780\/ref-21","doi-asserted-by":"publisher","first-page":"15713","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbagrm.2016.02.004","article-title":"Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation","volume":"1859","author":"Duan","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.7717\/peerj.14780\/ref-23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2018.08.014","article-title":"PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma","volume":"104","author":"Fan","year":"2018","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1101\/gr.166223.113","article-title":"An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease","volume":"24","author":"Faraji","year":"2014","journal-title":"Genome Research"},{"issue":"5 Suppl 1","key":"10.7717\/peerj.14780\/ref-25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1021\/jm401568s","article-title":"[1, 2, 4]triazolo[4, 3-a]phthalazines: inhibitors of diverse bromodomains","volume":"57","author":"Fedorov","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7327","key":"10.7717\/peerj.14780\/ref-27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"Pt 22","key":"10.7717\/peerj.14780\/ref-28","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1242\/jcs.02718","article-title":"Secrets of a double agent: CDK7 in cell-cycle control and transcription","volume":"118","author":"Fisher","year":"2005","journal-title":"Journal of Cell Science"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21541264.2018.1553483","article-title":"Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery","volume":"10","author":"Fisher","year":"2019","journal-title":"Transcription"},{"key":"10.7717\/peerj.14780\/ref-30","first-page":"D1008","article-title":"You bet-cha: a novel family of transcriptional regulators","volume":"6","author":"Florence","year":"2001","journal-title":"Frontiers in Bioscience: a Journal and Virtual Library"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.biocel.2008.10.024","article-title":"The tumour necrosis factor-alpha-mediated suppression of the CCAAT\/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation","volume":"41","author":"Foka","year":"2009","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"19","key":"10.7717\/peerj.14780\/ref-32","doi-asserted-by":"publisher","first-page":"e00040-17","DOI":"10.1128\/MCB.00040-17","article-title":"Transcriptional elongation control of hepatitis B virus covalently closed circular DNA transcription by super elongation complex and BRD4","volume":"37","author":"Francisco","year":"2017","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"issue":"9","key":"10.7717\/peerj.14780\/ref-34","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1158\/1078-0432.CCR-04-2625","article-title":"Down-regulation and growth inhibitory role of C\/EBPalpha in breast cancer","volume":"11","author":"Gery","year":"2005","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-35","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1073\/pnas.1424028112","article-title":"Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs","volume":"112","author":"Hah","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.14780\/ref-36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejpb.2018.11.018","article-title":"Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis","volume":"134","author":"Hassan","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","article-title":"Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers","volume":"58","author":"Hnisz","year":"2015","journal-title":"Molecular Cell"},{"issue":"22","key":"10.7717\/peerj.14780\/ref-39","doi-asserted-by":"publisher","first-page":"32628","DOI":"10.18632\/oncotarget.8701","article-title":"Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-40","doi-asserted-by":"publisher","first-page":"L177","DOI":"10.1152\/ajplung.00193.2017","article-title":"TBX4 is involved in the super-enhancer-driven transcriptional programs underlying features specific to lung fibroblasts","volume":"314","author":"Horie","year":"2018","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.7717\/peerj.14780\/ref-41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3908453","article-title":"Enhancement of lipid metabolism and hepatic stability in fat-induced obese mice by fermented cucurbita moschata extract","volume":"2018","author":"Hossain","year":"2018","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-42","doi-asserted-by":"publisher","first-page":"e9837","DOI":"10.1371\/journal.pone.0009837","article-title":"C\/EBPalpha and C\/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin","volume":"5","author":"House","year":"2010","journal-title":"PLOS ONE"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-43","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1128\/MCB.22.11.3794-3802.2002","article-title":"Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4","volume":"22","author":"Houzelstein","year":"2002","journal-title":"Molecular and Cellular Biology"},{"key":"10.7717\/peerj.14780\/ref-44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tox.2019.02.008","article-title":"Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C\/EBP\u03b1-SIRT1 pathway","volume":"417","author":"Hu","year":"2019","journal-title":"Toxicology"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Molecular Cell"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/105221614x13919976902219","article-title":"Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis","volume":"16","author":"Jia","year":"2014","journal-title":"Gene Expression"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1474-9726.2010.00617.x","article-title":"Epigenetic changes play critical role in age-associated dysfunctions of the liver","volume":"9","author":"Jin","year":"2010","journal-title":"Aging Cell"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-48","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1128\/MCB.21.11.3789-3806.2001","article-title":"c-Myc is a critical target for c\/EBPalpha in granulopoiesis","volume":"21","author":"Johansen","year":"2001","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)80924-1","article-title":"Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines","volume":"92","author":"Kadonaga","year":"1998","journal-title":"Cell"},{"issue":"24","key":"10.7717\/peerj.14780\/ref-50","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1016\/j.febslet.2014.10.036","article-title":"C\/EBPalpha controls mast cell function","volume":"588","author":"Kasakura","year":"2014","journal-title":"FEBS Letters"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2018-04-848044","article-title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","volume":"133","author":"Kusumoto","year":"2018","journal-title":"Blood"},{"issue":"44","key":"10.7717\/peerj.14780\/ref-52","doi-asserted-by":"publisher","first-page":"28545","DOI":"10.1074\/jbc.273.44.28545","article-title":"Biological role of the CCAAT\/enhancer-binding protein family of transcription factors","volume":"273","author":"Lekstrom-Himes","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1631\/jzus.B1900163","article-title":"Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer","volume":"20","author":"Leonard","year":"2019","journal-title":"Journal of Zhejiang University. Science"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-54","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1517\/14712598.2015.1029452","article-title":"Enhancer-associated RNAs as therapeutic targets","volume":"15","author":"Leveille","year":"2015","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"6945","key":"10.7717\/peerj.14780\/ref-55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature01763","article-title":"Transcription regulation and animal diversity","volume":"424","author":"Levine","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-56","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.18632\/oncotarget.6275","article-title":"Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.14780\/ref-57","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.omtn.2021.10.028","article-title":"Super-enhancer-driven lncRNA-DAW promotes liver cancer cell proliferation through activation of Wnt\/beta-catenin pathway","volume":"26","author":"Liang","year":"2021","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"9","key":"10.7717\/peerj.14780\/ref-58","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.4049\/jimmunol.171.9.4708","article-title":"IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B","volume":"171","author":"Lin","year":"2003","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-59","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1038\/s41467-021-24843-w","article-title":"Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis","volume":"12","author":"Liu","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2006.06.035","article-title":"Interchromosomal interactions and olfactory receptor choice","volume":"126","author":"Lomvardas","year":"2006","journal-title":"Cell"},{"issue":"14","key":"10.7717\/peerj.14780\/ref-61","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1158\/0008-5472.CAN-07-0139","article-title":"Genetic ablation of CCAAT\/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis","volume":"67","author":"Loomis","year":"2007","journal-title":"Cancer Research"},{"issue":"13","key":"10.7717\/peerj.14780\/ref-62","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1073\/pnas.87.13.5069","article-title":"Multiple liver-specific factors bind to the hepatitis B virus core\/pregenomic promoter: trans-activation and repression by CCAAT\/enhancer binding protein","volume":"87","author":"Lopez-Cabrera","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"issue":"18","key":"10.7717\/peerj.14780\/ref-64","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/j.ejca.2012.06.027","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K\/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies","volume":"48","author":"Mahadevan","year":"2012","journal-title":"European Journal of Cancer"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-65","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrg2901","article-title":"The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation","volume":"11","author":"Malik","year":"2010","journal-title":"Nature Reviews Genetics"},{"issue":"43","key":"10.7717\/peerj.14780\/ref-66","doi-asserted-by":"publisher","first-page":"27176","DOI":"10.1074\/jbc.271.43.27176","article-title":"Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase","volume":"271","author":"Marshall","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"issue":"21","key":"10.7717\/peerj.14780\/ref-67","doi-asserted-by":"publisher","first-page":"12335","DOI":"10.1074\/jbc.270.21.12335","article-title":"Purification of P-TEFb, a transcription factor required for the transition into productive elongation","volume":"270","author":"Marshall","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-68","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/carcin\/bgp306","article-title":"Transcription coactivator PBP\/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse","volume":"31","author":"Matsumoto","year":"2010","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.7717\/peerj.14780\/ref-69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1872-034X.2007.00074.x","article-title":"In vivo transfection of C\/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice","volume":"37","author":"Mei","year":"2007","journal-title":"Hepatology Research: the Official Journal of the Japan Society of Hepatology"},{"issue":"395","key":"10.7717\/peerj.14780\/ref-70","doi-asserted-by":"publisher","first-page":"eaai9118","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA Wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-71","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1101\/gad.308619.117","article-title":"The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription","volume":"32","author":"Mikhaylichenko","year":"2018","journal-title":"Genes & Development"},{"issue":"7","key":"10.7717\/peerj.14780\/ref-72","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-73","doi-asserted-by":"publisher","first-page":"e01788-17","DOI":"10.1128\/JVI.01788-17","article-title":"TIP60 complex inhibits hepatitis B virus transcription","volume":"92","author":"Nishitsuji","year":"2018","journal-title":"Journal of Virology"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-74","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1248\/cpb.c16-00225","article-title":"BET bromodomain as a target of epigenetic therapy","volume":"64","author":"Noguchi-Yachide","year":"2016","journal-title":"Chemical and Pharmaceutical Bulletin"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg2957","article-title":"Enhancer function: new insights into the regulation of tissue-specific gene expression","volume":"12","author":"Ong","year":"2011","journal-title":"Nature Reviews. Genetics"},{"issue":"7","key":"10.7717\/peerj.14780\/ref-76","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1074\/jbc.271.7.3891","article-title":"DNA binding specificity of the CCAAT\/enhancer-binding protein transcription factor family","volume":"271","author":"Osada","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-77","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/nu11030494","article-title":"Lonicera caerulea extract attenuates non-alcoholic fatty liver disease in free fatty acid-induced HepG2 hepatocytes and in high fat diet-fed mice","volume":"11","author":"Park","year":"2019","journal-title":"Nutrients"},{"issue":"30","key":"10.7717\/peerj.14780\/ref-78","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1038\/sj.onc.1203674","article-title":"Hepatitis B virus-X protein upregulates the expression of p21waf1\/cip1 and prolongs G1\u2013>S transition via a p53-independent pathway in human hepatoma cells","volume":"19","author":"Park","year":"2000","journal-title":"Oncogene"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-79","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1158\/0008-5472.CAN-18-0367","article-title":"Super-enhancer-associated long noncoding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma","volume":"79","author":"Peng","year":"2019","journal-title":"Cancer Research"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-80","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","article-title":"Controlling the elongation phase of transcription with P-TEFb","volume":"23","author":"Peterlin","year":"2006","journal-title":"Molecular Cell"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2014.06.015","article-title":"Enhancer function: mechanistic and genome-wide insights come together","volume":"55","author":"Plank","year":"2014","journal-title":"Molecular Cell"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","article-title":"What are super-enhancers?","volume":"47","author":"Pott","year":"2015","journal-title":"Nature Genetics"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-83","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/en.2005-1507","article-title":"knocking down liver ccaat\/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db\/db mice","volume":"147","author":"Qiao","year":"2006","journal-title":"Endocrinology"},{"issue":"Pt 3","key":"10.7717\/peerj.14780\/ref-84","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","volume":"365","author":"Ramji","year":"2002","journal-title":"The Biochemical Journal"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/hep.26669","article-title":"Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo","volume":"59","author":"Reebye","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-86","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatology International"},{"issue":"15","key":"10.7717\/peerj.14780\/ref-87","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-20-0414","article-title":"MTL-CEBPA, a small activating rna therapeutic upregulating C\/EBP-alpha, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial","volume":"26","author":"Sarker","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/2159-8290.CD-13-0018","article-title":"Targeting MYCN: a good BET for improving neuroblastoma therapy?","volume":"3","author":"Schnepp","year":"2013","journal-title":"Cancer Discovery"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-enhancer-driven transcriptional dependencies in cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends in Cancer"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-90","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/nu10111802","article-title":"Ishige okamurae extract suppresses obesity and hepatic steatosis in high fat diet-induced obese mice","volume":"10","author":"Seo","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-91","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14348\/molcells.2018.2297","article-title":"Targeting super-enhancers for disease treatment and diagnosis","volume":"41","author":"Shin","year":"2018","journal-title":"Molecules and Cells"},{"issue":"8","key":"10.7717\/peerj.14780\/ref-92","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng.3606","article-title":"Hierarchy within the mammary STAT5-driven Wap super-enhancer","volume":"48","author":"Shin","year":"2016","journal-title":"Nature Genetics"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-93","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.celrep.2014.04.042","article-title":"Transcription factor cooperativity in early adipogenic hotspots and super-enhancers","volume":"7","author":"Siersb\u00e6k","year":"2014","journal-title":"Cell Reports"},{"issue":"11","key":"10.7717\/peerj.14780\/ref-94","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-15-0976","article-title":"Single agent and synergistic activity of the First-in-Class dual PI3K\/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma","volume":"15","author":"Singh","year":"2016","journal-title":"Molecular Cancer Therapeutics"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-95","doi-asserted-by":"publisher","first-page":"561","DOI":"10.5152\/tjg.2018.18032","article-title":"Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity","volume":"29","author":"Solay","year":"2018","journal-title":"The Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology"},{"issue":"7042","key":"10.7717\/peerj.14780\/ref-96","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature03574","article-title":"Interchromosomal associations between alternatively expressed loci","volume":"435","author":"Spilianakis","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-97","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2613.1998.00082.x","article-title":"The C\/EBP family of transcription factors in the liver and other organs","volume":"79","author":"Takiguchi","year":"1998","journal-title":"International Journal of Experimental Pathology"},{"issue":"22","key":"10.7717\/peerj.14780\/ref-98","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.1158\/0008-5472.CAN-04-4486","article-title":"CCAAT\/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma","volume":"65","author":"Tan","year":"2005","journal-title":"Cancer Research"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-020-01195-5","article-title":"Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis","volume":"19","author":"Tan","year":"2020","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-100","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/mol.112.081661","article-title":"BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis","volume":"83","author":"Tang","year":"2013","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.7717\/peerj.14780\/ref-101","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10495-012-0700-y","article-title":"C\/EBP-alpha ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo","volume":"17","author":"Tao","year":"2012","journal-title":"Apoptosis: an International Journal on Programmed Cell Death"},{"issue":"10","key":"10.7717\/peerj.14780\/ref-102","first-page":"13102","article-title":"The role of C\/EBP-alpha expression in human liver and liver fibrosis and its relationship with autophagy","volume":"8","author":"Tao","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"6","key":"10.7717\/peerj.14780\/ref-103","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1002\/hep.30544","article-title":"Aberrant super-enhancer landscape in human hepatocellular carcinoma","volume":"69","author":"Tsang","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-104","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00432-008-0448-5","article-title":"Reduced expression of C\/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival","volume":"135","author":"Tseng","year":"2009","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"12","key":"10.7717\/peerj.14780\/ref-105","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.ymthe.2017.07.018","article-title":"Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer","volume":"25","author":"Voutila","year":"2017","journal-title":"Molecular Therapy"},{"issue":"7","key":"10.7717\/peerj.14780\/ref-106","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1172\/JCI41933","article-title":"Elimination of C\/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice","volume":"120","author":"Wang","year":"2010","journal-title":"Journal of Clinical Investigation"},{"issue":"5227","key":"10.7717\/peerj.14780\/ref-107","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.7652557","article-title":"Impaired energy homeostasis in C\/EBP alpha knockout mice","volume":"269","author":"Wang","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-108","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2009.01.060","article-title":"Over-expression of C\/EBP-alpha induces apoptosis in cultured rat hepatic stellate cells depending on p53 and peroxisome proliferator-activated receptor-gamma","volume":"380","author":"Wang","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-109","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ol.2015.3570","article-title":"BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway","volume":"10","author":"Wang","year":"2015","journal-title":"Oncology Letters"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-110","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hep.22979","article-title":"p21 is required for dextrose-mediated inhibition of mouse liver regeneration","volume":"50","author":"Weymann","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.7717\/peerj.14780\/ref-111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.7717\/peerj.14780\/ref-112","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1186\/s12864-015-1905-6","article-title":"High-density P300 enhancers control cell state transitions","volume":"16","author":"Witte","year":"2015","journal-title":"BMC Genomics"},{"key":"10.7717\/peerj.14780\/ref-113","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.10.039","article-title":"Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis","volume":"525","author":"Wu","year":"2022","journal-title":"Cancer Letters"},{"issue":"8","key":"10.7717\/peerj.14780\/ref-114","doi-asserted-by":"publisher","first-page":"e72967","DOI":"10.1371\/journal.pone.0072967","article-title":"BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models","volume":"8","author":"Wyce","year":"2013","journal-title":"PLOS ONE"},{"issue":"5-6","key":"10.7717\/peerj.14780\/ref-115","doi-asserted-by":"publisher","first-page":"e23422","DOI":"10.1002\/dvg.23422","article-title":"The mechanism and function of super enhancer RNA","volume":"59","author":"Xiao","year":"2021","journal-title":"Genesis"},{"issue":"8","key":"10.7717\/peerj.14780\/ref-116","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1053\/j.gastro.2018.02.018","article-title":"Super-enhancer-driven long non-coding RNA LINC01503, regulated by TP63, Is over-expressed and oncogenic in squamous cell carcinoma","volume":"154","author":"Xie","year":"2018","journal-title":"Gastroenterology"},{"issue":"10","key":"10.7717\/peerj.14780\/ref-117","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.metabol.2016.07.001","article-title":"BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver","volume":"65","author":"Yamada","year":"2016","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"4","key":"10.7717\/peerj.14780\/ref-118","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Molecular Cell"},{"issue":"20","key":"10.7717\/peerj.14780\/ref-119","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.7150\/thno.45349","article-title":"Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.7717\/peerj.14780\/ref-120","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0394632015572070","article-title":"BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2015","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"15","key":"10.7717\/peerj.14780\/ref-121","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1128\/MCB.00176-07","article-title":"The locus control region activates serpin gene expression through recruitment of liver-specific transcription factors and RNA polymerase II","volume":"27","author":"Zhao","year":"2007","journal-title":"Molecular and Cellular Biology"},{"key":"10.7717\/peerj.14780\/ref-122","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-981-10-4310-9_13","article-title":"Treatment of Liver Cancer by C\/EBPA saRNA","volume":"983","author":"Zhao","year":"2017","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"3","key":"10.7717\/peerj.14780\/ref-123","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1007\/s13277-015-4109-4","article-title":"Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.7717\/peerj.14780\/ref-124","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fphar.2016.00462","article-title":"Targeting mechanotransduction at the transcriptional level: YAP and BRD4 are novel therapeutic targets for the reversal of liver fibrosis","volume":"7","author":"Zhubanchaliyev","year":"2016","journal-title":"Frontiers in Pharmacology"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/14780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14780.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14780.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T03:28:30Z","timestamp":1674790110000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/14780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":124,"alternative-id":["10.7717\/peerj.14780"],"URL":"https:\/\/doi.org\/10.7717\/peerj.14780","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.14780v0.1\/reviews\/4","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.2\/reviews\/3","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.2\/reviews\/4","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.1\/reviews\/1","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.14780v0.1\/reviews\/3","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"article-number":"e14780"}}